ZL-1310
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ZL-1310, covering 2026-04-03 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE) [Phase 3]